An increasing body of evidence shows that PTEN functions as a tumour suppressor gene in some tissues, and its tumour suppressor activity is dependent on its lipid phosphatase activity, which negatively regulates the PI3K-AKT-mTOR pathway [21]. This evidence concerns the gene AKT1 and neoplasm.